Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Biotinylated Human IFN-alpha / beta R1 Protein, His,Avitag (Cat. No. IF1-H82E3) captured on Biotin CAP-Series S Sensor Chip can bind Human IFN-alpha 1, Fc Tag (Cat. No. IFA-H5258) with an affinity constant of 0.177 μM as determined in a SPR assay (Biacore 8K) (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant human interferon α2b biosimilar (Zhejiang Hansheng) | Approved | Zhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma | 莱福隆 | Mainland China | Virus Diseases; Neoplasms | Zhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma | 1999-01-01 | Virus Diseases; Neoplasms | Details | |
| Interferon beta (Toray/Daiichi Sankyo) | DL-8234 | Approved | Toray Industries Inc | Feron | Japan | Hepatitis C | Toray Industries Inc, Daiichi Sankyo Co Ltd | 1985-04-01 | Medulloblastoma; Glioblastoma; Hepatitis B; Hepatitis C; Astrocytoma; Melanoma | Details |
| Recombinant human interferon alfa-2b (Harbin Pharmaceutical Group Bioengineering) | Approved | Harbin Pharmaceutical Group Holding Co Ltd | 里亚美, 利分能 | Mainland China | Condylomata Acuminata; Varicella Zoster Virus Infection; Hepatitis, Viral, Human; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Multiple Myeloma | Harbin Pharmaceutical Group Pharmaceutical Co Ltd | 1996-01-01 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Hairy Cell; Varicella Zoster Virus Infection; Multiple Myeloma; Hepatitis, Viral, Human; Lymphoma, Non-Hodgkin; Condylomata Acuminata | Details | |
| Recombinant human interferon α2b biosimilar (Harbin High-Tech White Swan Pharmaceutical) | Approved | Harbin High-Tech Group Baitian'Er Pharmaceutical Co Ltd | Fu Li Sheng | Leukemia, Hairy Cell; Hepatitis; Multiple Myeloma; Leukemia, Myeloid, Chronic-Phase; Lymphoma, Non-Hodgkin; Condylomata Acuminata; Herpes Zoster | Details | |||||
| Anifrolumab | MEDI-546; MDX-1333 | Approved | Medimmune Llc, Medarex | SAPHNELO | EU | Lupus Erythematosus, Systemic | Astrazeneca Ab | 2021-07-30 | Atherosclerosis; Scleroderma, Systemic; Sjogren's Syndrome; Lupus Nephritis; Lupus Erythematosus, Systemic; Cardiovascular Diseases | Details |
This web search service is supported by Google Inc.
A-Z
